» Articles » PMID: 38643749

Biomarkers of NRF2 Signalling: Current Status and Future Challenges

Abstract

The cytoprotective transcription factor NRF2 regulates the expression of several hundred genes in mammalian cells and is a promising therapeutic target in a number of diseases associated with oxidative stress and inflammation. Hence, an ability to monitor basal and inducible NRF2 signalling is vital for mechanistic understanding in translational studies. Due to some caveats related to the direct measurement of NRF2 levels, the modulation of NRF2 activity is typically determined by measuring changes in the expression of one or more of its target genes and/or the associated protein products. However, there is a lack of consensus regarding the most relevant set of these genes/proteins that best represents NRF2 activity across cell types and species. We present the findings of a comprehensive literature search that according to stringent criteria identifies GCLC, GCLM, HMOX1, NQO1, SRXN1 and TXNRD1 as a robust panel of markers that are directly regulated by NRF2 in multiple cell and tissue types. We assess the relevance of these markers in clinically accessible biofluids and highlight future challenges in the development and use of NRF2 biomarkers in humans.

Citing Articles

Resistance to Radiation Enhances Metastasis by Altering RNA Metabolism.

Kumar A, Kishimoto K, Goel H, Wisniewski C, Li R, Pacheco B bioRxiv. 2025; .

PMID: 40060410 PMC: 11888214. DOI: 10.1101/2025.02.19.638943.


Evidence for a Functional Link Between the Nrf2 Signalling Pathway and Cytoprotective Effect of S-Petasin in Human Retinal Pigment Epithelium Cells Exposed to Oxidative Stress.

Pizzoferrato M, Lazzarino G, Brancato A, Tabolacci E, Clementi M, Tringali G Antioxidants (Basel). 2025; 14(2).

PMID: 40002367 PMC: 11851853. DOI: 10.3390/antiox14020180.


Targeting ferroptosis to enhance the efficacy of mesenchymal stem cell-based treatments for intervertebral disc degeneration.

Xu Y, Xu X, Chai R, Wu X Int J Biol Sci. 2025; 21(3):1222-1241.

PMID: 39897051 PMC: 11781166. DOI: 10.7150/ijbs.107021.


Nrf2 induction potency of plant-derived compounds determined using an antioxidant response element luciferase reporter and conventional NAD(P)H-quinone acceptor oxidoreductase 1 activity assay.

Tamaru E, Kokubu D, Ushida Y, Itoh K BMC Res Notes. 2024; 17(1):373.

PMID: 39707451 PMC: 11660871. DOI: 10.1186/s13104-024-07038-6.


Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway.

Han Q, Shi J, Yu Y, Yuan H, Guo Y, Liu X Front Pharmacol. 2024; 15:1497733.

PMID: 39600362 PMC: 11589554. DOI: 10.3389/fphar.2024.1497733.


References
1.
Sreerama L, Hedge M, Sladek N . Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin Cancer Res. 1995; 1(10):1153-63. View

2.
Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M . Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol. 1995; 15(8):4184-93. PMC: 230657. DOI: 10.1128/MCB.15.8.4184. View

3.
Yeager R, Reisman S, Aleksunes L, Klaassen C . Introducing the "TCDD-inducible AhR-Nrf2 gene battery". Toxicol Sci. 2009; 111(2):238-46. PMC: 2742581. DOI: 10.1093/toxsci/kfp115. View

4.
Harkonen J, Polonen P, Deen A, Selvarajan I, Teppo H, Dimova E . A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies. Redox Biol. 2023; 61:102644. PMC: 10011429. DOI: 10.1016/j.redox.2023.102644. View

5.
Liu P, Kerins M, Tian W, Neupane D, Zhang D, Ooi A . Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells. J Biol Chem. 2019; 294(48):18131-18149. PMC: 6885608. DOI: 10.1074/jbc.RA119.009591. View